Dr Guido Middeler takes over management of HÄLSA Pharma GmbH

Dr Guido Middeler is the new General Manager of HÄLSA Pharma GmbH.

Dr Thilo Sandner is Managing Partner of the pharmaceutical consulting company and HÄLSA parent company Diapharm GmbH & Co. KG.

Lübeck, 01/31/2020 – Dr Guido Middeler has taken over management of HÄLSA Pharma GmbH and its locations in Lübeck and Münster with immediate effect. The company is a subsidiary of Diapharm (www.diapharm.com), the pharmaceutical consultancy. HÄLSA Pharma performs regulatory functions for a wide range of customers from the pharmaceutical industry with regard to the approval and marketing of medicinal products and medical devices. From the application as a pharmaceutical company to batch releases and the safeguarding of vigilance requirements, HÄLSA offers an all-round carefree package for medicinal products as well as for medical devices. In addition, HÄLSA assumes full responsibility as a legal manufacturer and acts as the European Authorised Representative on behalf of its clients.

Dr Guido Middeler previously led the medical devices team at Diapharm. He is taking on the additional task as General Manager of HÄLSA Pharma GmbH as part of the restructuring of Diapharm initiated by its Managing Partner Dr Thilo Sandner.

(approx. 1,050 characters)

Share:  
News

 

Contact us!
I agree to the privacy policy. I consent that reports related to products supported by Diapharm may be disclosed to a third party.
Cookie Settings
X

We are using cookies.

We use third party cookies for usage statistics and to further improve our website.

I accept

Individual Cookie Settings

Only accept required cookies.

Privacy Notes Imprint

X

Privacy settings

Here is an overview of all cookies use

Save

BackOnly accept required cookies.

Privacy Notes Imprint